Vita Life Sciences (ASX:VLS) EV-to-Revenue : 1.26 (As of Jun. 25, 2025)

View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Vita Life Sciences's enterprise value is A$99.86 Mil. Vita Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$79.51 Mil. Therefore, Vita Life Sciences's EV-to-Revenue for today is 1.26.

The historical rank and industry rank for Vita Life Sciences's EV-to-Revenue or its related term are showing as below:

ASX:VLS' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5 Med: 1.06 Max: 2.53
Current: 1.25

During the past 13 years, the highest EV-to-Revenue of Vita Life Sciences was 2.53. The lowest was 0.50. And the median was 1.06.

ASX:VLS's EV-to-Revenue is ranked better than
73.25% of 972 companies
in the Drug Manufacturers industry
Industry Median: 2.405 vs ASX:VLS: 1.25

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-25), Vita Life Sciences's stock price is A$2.38. Vita Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$1.43. Therefore, Vita Life Sciences's PS Ratio for today is 1.67.

Vita Life Sciences EV-to-Revenue Historical Data

The historical data trend for Vita Life Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences EV-to-Revenue Chart

Vita Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

0.89

1.56

0.92

0.77

1.07

Vita Life Sciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															0.92	-	0.77	-	1.07

Competitive Comparison of Vita Life Sciences's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vita Life Sciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Vita Life Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Vita Life Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	99.864	/	79.505
	=	1.26

Vita Life Sciences's current Enterprise Value is A$99.86 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vita Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$79.51 Mil.

Vita Life Sciences (ASX:VLS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Vita Life Sciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.38	/	1.429
	=	1.67

Vita Life Sciences's share price for today is A$2.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was A$1.43.

Vita Life Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines